KAREN JOHNSON: Open Payments
NPI 1063703510 · SCHERTZ, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$600 in 32 payments from 14 companies in 2025. Trend: 2023 $1,241 · 2024 $1,194 · 2025 $600
Food & beverage: $600
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $152 |
| Globus Medical, Inc. | 1 | $75 |
| Novo Nordisk Inc | 3 | $64 |
| Lilly USA, LLC | 3 | $63 |
| PFIZER INC. | 4 | $59 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| Exact Sciences Corporation | 2 | $28 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $26 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
Products named: VRAYLAR, Senza, NURTEC ODT, MOUNJARO, Wegovy, QULIPTA, AIRSUPRA, UBRELVY.
Industry payments across TX — which companies pay providers there.
